Novanta Inc. · NASDAQ:NOVT
Novanta — Merger or Acquisition (November 2023)
12 slides from Novanta's merger presentation, Nov 14, 2023
Slide 1: Novanta to acquire Motion Solutions
ANNOUNCEMENT Novanta to acquire NOVEMBER 14, 2023 NASDAQ: NOVT
Slide 2: Safe Harbor Statement
Safe Harbor Statement Certain statements in this presentation, including those related to the Motion Solutions acquisition, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and are based on current expectations and assumptions that are subje
Slide 3: Motion Solutions Profile
Motion Solutions Profile Trusted engineering partner to market-leading OEMs in medical, life sciences, and advanced industrial applications. ~$85M ~65% >110 ANNUAL SALES MEDICAL / LIFE SCIENCES EMPLOYEES 8% TO 10% CAGR CONFIDENTIAL AND PROPRIETARY
Slide 4: Motion Solutions Overview and Deal Rationale
MOTION SOLUTIONS OVERVIEW Trusted engineering partner to market-leading OEMs in medical, life sciences, and advanced industrial applications. Designs and manufactures DEAL RATIONALE high-precision, customized subsystems and components Deepens presence into secular Strong business model and growth pr
Slide 5: Outstanding Strategic Fit
Outstanding Strategic Fit Deepens Presence Increases Value of in Precision Medicine Novanta’s Solutions New subsystem solution capability, Offering targeting life sciences, spatial biology, Designed into OEM systems on proteomics, single cell and DNA a sole source basis applications Offer new soluti
Slide 6: Strong Presence in Medical and Life Science
Strong Presence in Medical and Life Science Intelligent Motion Subsystems are Critical for sample positioning and alignment in Medical and Life Science Applications Deep, long-term OEM customer partnerships enabled by strong engineer-to-engineer relationships History of quality and reliability leadi
Slide 7: Attractive Secular Growth Profile
Attractive Secular Growth Profile Proteomics Genomics Motion Solutions serves large, attractive markets with strong, durable tailwinds LIFE SCIENCES HSD to LDD market growth outlook Transform disease research (e.g. oncology), drug discovery, and clinical development MEDICAL DEVICES MSD to HSD market
Slide 8: Expands Solutions Offering for Attractive Customer Base
Expands Solutions Offering Increasing content and for Attractive Customer Base breadth of Novanta’s intelligent solutions in high growth applications Expands intelligent subsystem solutions into high- growth Precision Medicine, Medical, and Precision Manufacturing applications Strong synergy with ex
Slide 9: Adds New Talent and Capabilities
Adds New Talent and Capabilities CAPABILITIES FACILITY ~110 employees, Close collaboration Headquartered in Large clean room including significant with customer R&D Irvine, California, capacity, dedicated engineering and engineering teams with new cutting- R&D labs competencies edge facility Market
Slide 10: Financial Highlights
Financial Highlights $189M UPFRONT PURCHASE PRICE FINANCIAL PROFILE ROIC +10% by Year 3 ~$85M Revenue growth rate accretive ANNUAL SALES Adj. Gross Margin % dilutive Year 1 Expected to close in 1Q24, ~12x A DJ . E B I T DA M U LT I P L E financed through credit facility @ 6.6% cost of debt CONFIDENT
Slide 11: Thank You
Thank You CONFIDENTIAL AND PROPRIETARY
Slide 12: Motion Solutions Product Offerings
Motion Solutions Product Offerings A DVA N C E D M OT I O N S U B SYS T E M S Customized Solutions, Precision Stages, Piezo Stages PRECISION MOTION COMPONENTS Controls, Drives, Motors, Gearheads, Sensors, Safety CONFIDENTIAL AND PROPRIETARY